ZA842926B - Condensed,seven-membered ring compounds and their use - Google Patents

Condensed,seven-membered ring compounds and their use

Info

Publication number
ZA842926B
ZA842926B ZA842926A ZA842926A ZA842926B ZA 842926 B ZA842926 B ZA 842926B ZA 842926 A ZA842926 A ZA 842926A ZA 842926 A ZA842926 A ZA 842926A ZA 842926 B ZA842926 B ZA 842926B
Authority
ZA
South Africa
Prior art keywords
condensed
membered ring
ring compounds
compounds
membered
Prior art date
Application number
ZA842926A
Other languages
English (en)
Inventor
Hirosada Sugihara
Kohei Nishikawa
Katsumi Ito
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ZA842926B publication Critical patent/ZA842926B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA842926A 1983-04-22 1984-04-18 Condensed,seven-membered ring compounds and their use ZA842926B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1983/000127 WO1984004306A1 (fr) 1983-04-22 1983-04-22 C0mposes cycliques a 7 membres fusionnes et leur procede de preparation

Publications (1)

Publication Number Publication Date
ZA842926B true ZA842926B (en) 1984-12-24

Family

ID=13789981

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA842926A ZA842926B (en) 1983-04-22 1984-04-18 Condensed,seven-membered ring compounds and their use

Country Status (6)

Country Link
JP (1) JPS59205372A (fr)
AR (1) AR244217A1 (fr)
DK (1) DK196884A (fr)
SU (1) SU1526583A3 (fr)
WO (1) WO1984004306A1 (fr)
ZA (1) ZA842926B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608283A (ja) * 1983-06-29 1985-01-17 Mitsui Toatsu Chem Inc ベンゾチアゼピン誘導体およびその製造方法
JPS60174775A (ja) * 1984-02-21 1985-09-09 Mitsui Toatsu Chem Inc ベンゾチアゼピン誘導体
JPS60239475A (ja) * 1984-05-15 1985-11-28 Mitsui Toatsu Chem Inc 置換ベンゾチアゼピン誘導体
JPS61148171A (ja) * 1984-12-21 1986-07-05 Mitsui Toatsu Chem Inc ベンゾチアゼピン誘導体
US4692522A (en) * 1985-04-01 1987-09-08 Merck & Co., Inc. Benzofused lactams useful as cholecystokinin antagonists
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
WO1998041510A1 (fr) * 1997-03-14 1998-09-24 Shionogi & Co., Ltd. Nouveaux derives du benzolactame et compositions medicamenteuses les contenant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460579A (en) * 1983-02-28 1984-07-17 E. R. Squibb & Sons, Inc. Thiazine and thiazepine containing compounds

Also Published As

Publication number Publication date
DK196884A (da) 1984-10-23
JPH0564144B2 (fr) 1993-09-14
DK196884D0 (da) 1984-04-17
WO1984004306A1 (fr) 1984-11-08
JPS59205372A (ja) 1984-11-20
AR244217A1 (es) 1993-10-29
SU1526583A3 (ru) 1989-11-30

Similar Documents

Publication Publication Date Title
DE3273387D1 (en) Tetrahydrophthalimide compounds, and their production and use
DE3176517D1 (en) Beta-lactam compounds, their preparation and use
GB2133008B (en) 1,4-benzodiazepine derivatives
PH22975A (en) Substituted hydrazones, process for the preparation and their use
OA08698A (en) Mocrolide compounds, their preparation and their use.
YU26482A (en) Locking ring
DE3367607D1 (en) Basic compounds, their preparation and their use
EP0133459A3 (en) Ring
DE3463041D1 (en) Tributylphenolether-glycidyl-sulphonates, process for their preparation and their use
DE3366634D1 (en) Chlorinated polyethylene, process for its preparation and use therof
ZA83592B (en) Corynantheine derivatives,processes for their preparation,and their use
ZA842926B (en) Condensed,seven-membered ring compounds and their use
DE3460445D1 (en) Pyridotriazolium compounds, and their production and use
ZA851293B (en) Condensed seven-membered compounds,their production and use
ZA841366B (en) Compounds,processes and use
IL74004A0 (en) Condensed seven-membered ring compounds and their production and use
EP0098430A3 (en) Triazine compounds, their preparation and their use
CY1521A (en) Substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols,preparation and use thereof
DE3362008D1 (en) Quinone compounds, their production and use
ZA872140B (en) Microlide compounds,their preparation and their use
ZA846075B (en) Condensed seven-membered ring compounds and their production and use
PH17601A (en) Trifluoromethanessulfonanilides,and their use
ZA844618B (en) Tetrahydropyridazinone derivatives,processes for their preparation and their use
ZA872721B (en) Compound,process and use
DE3261398D1 (en) Improved locking ring